Science Gone Social

Scientists are beginning to embrace social media as a viable means of communicating with public audiences.

Written bySara K. Yeo, Dietram A. Scheufele, Dominique Brossard, Michael A. Xenos, and Michael A. Cacciatore
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

© DUSAN PETRICICOn March 20, 2013, Senator Tom Coburn’s (R-Oklahoma) proposed amendment to block federal funding for political science passed in the US House of Representatives. Around the same time, in a letter to the National Science Foundation (NSF), the senator urged that research ranging from robotics to ecology, among others, be ineligible for federal funding. Additionally, the High Quality Research Act, proposed by Congressman Lamar Smith (R-Texas) in April of last year, was designed to ensure that NSF only supports projects addressing problems “that are of the utmost importance to society at large.” The ability to communicate the societal value of basic research to nonacademic audiences is therefore morphing from an optional soft skill to a crucial tool for scientists who are competing over finite or shrinking resources for research.

National Academy of Sciences President Ralph Cicerone argued as early as 2006 that “scientists themselves must do a better job of communicating directly to the public,” taking advantage of “new, non-traditional outlets” on the Internet (In Focus, 6, 2006). In 2011, Laura Van Eperen of the strategic communications company Van Eperen & Company, along with National Institutes of Health researcher Francesco Marincola, called for scientists to use social media, such as Facebook or Twitter, to “communicate to the masses” (J Transl Med, 9:199, 2011).

So have scientists heeded this call? To find out, we conducted a survey of tenure-track scientists at the University of Wisconsin–Madison, polling them on their use of social media for science-related purposes, their attitudes toward such use, and their political ideology. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies